This section synthesizes key federal statutes and regulations governing how drug manufacturers must label products in the United States. "Labeling" includes labels, inserts, and promotional materials. Any manufacturer-originated material is subject to FDA review. This includes rules that apply to both prescription (Rx) and over-the-counter (OTC) drugs.
🦅 Federal Law Overview:
- 🔗 FDC, FDCA, & Amendments (🔗 Link To)
- 🔗 Extended Packaging & Labeling Policy (🔗 Link To)
- 🔗 Controlled Substance Policy (🔗 Link To)
| Requirement | Description | Legal Basis |
|---|---|---|
| Drug Identity | Brand and generic name of active ingredient clearly stated | 🦅 21 CFR §201.10; FDCA §502(e) |
| Strength | Quantity of active ingredient per unit (e.g. mg per tablet) | 🦅 21 CFR §201.10(b); FDCA §502(a) |
| Inactive Ingredients (if OTC) | Excipients used in production must be listed in the Drug Facts panel | 🦅 FDCA §502(e); 21 CFR §201.66(c)(8) |
| Dosage Form | Physical form (e.g. capsule, solution) and route (oral, topical, etc.) | 🦅 21 CFR §201.100(b); USP standards |
| Quantity Statement | Net contents by weight, volume, or count | 🦅 FDCA §502(b)(2); 21 CFR §201.51 |
| National Drug Code (NDC) | FDA-assigned 11-digit code identifying manufacturer, drug, and package; sometimes includes NATO Stock Number (NSN) for NATO countries | 🦅 FDCA §510; 21 CFR §207.35 |
| "Rx Only" Designation (if rx) | Required on prescription-only drugs | 🦅 FDCA §503(b)(4) (as amended by FDA Modernization Act of 1997) |
| 🔐 Controlled Substance Schedule (if controlled) | DEA Schedule I–V must be shown | 🦅 21 CFR §1302.04; CSA (21 USC §825) |
| 🔐 DEA Order Form Requirement (if CII) | Schedule II drugs require DEA Form 222 or CSOS for ordering | 🦅 CSA 21 USC §828; 21 CFR §1305 |
| Intended Use & Directions | Declaration of intended use & directions; including recommended dosage and frequency, where applicable. | 🦅 FDCA §502(f); 21 CFR §201.5 |
| Warnings | Required safety warnings including contraindications, adverse effects, storage, and Black Box Warnings if applicable | 🦅 FDCA §502(f); 21 CFR §201.57 (Rx); 21 CFR §201.66 (OTC) |
| Storage Requirements | Storage conditions to prevent degradation (e.g., temperature, humidity, light) | 🦅 21 CFR §201.18; 21 CFR §211.142 |
| Dispensing Container Required (if rx) | Must be dispensed in a container that preserves stability within the labeled use period | 🦅 21 CFR §211.94; USP <659> Packaging & Storage |
| Manufacturer Info | Name, business address, and phone number of the manufacturer, packer, or distributor | 🦅 FDCA §502(b); 21 CFR §201.1 |
| Batch/ Lot Number | A unique identifier for the production batch to facilitate tracking and recalls if necessary | 🦅 21 CFR §211.130(e); §211.137 |
| Manufacture & Expiration Dates | date of manufacture and the expiration or “use by” date to ensure drug potency and safety | 🦅 21 CFR §211.130(e); §211.137 |
| Barcoding & Serialization Requirements | Serial Numbers; Linear (1D) and 2D barcodes per DSCSA, encoding NDC, lot, and expiration | 🦅 DSCSA (FDCA §582); 21 CFR §201.25 |
| Tamper-Evident Packaging | Required for most OTC drugs to demonstrate integrity | 🦅 21 CFR §211.132; 21 CFR §211.125 |
| Language | English required; other languages optional or supplemental | 🦅 21 CFR §201.15(c); FDCA §502(c) |
| Patient Package Insert (PPI) (conditional) | Required for certain drug classes (e.g. oral contraceptives, estrogens) and drugs under REMS | 🦅 21 CFR §208; FDCA §505-1 (REMS) |
| 📰 Medication Guide (MedGuide) (conditional) | Required when FDA determines information is necessary to prevent serious adverse effects, ensure proper use, or address risks of non-adherence | 🦅 21 CFR §208.1; FDCA §505-1(e) |
🛡️ The ISMP recommends Tall Man Lettering to distinguish look-alike drug names (e.g. predniSONE vs prednisoLONE)
Manufacturer Stock Label
The NDC is a unique 10- or 11-digit, 3-segment number that identifies all FDA-approved drug products. It is required on prescription drug labels and often found on OTC products as well.
| Segment | Digits | Description |
|---|---|---|
| Labeler Code | 5 | Identifies the manufacturer or repackager (FDA-assigned) |
| Product Code | 3–4 | Identifies the specific strength, dosage form, and formulation (Manufacturer-assigned) |
| Package Code | 1–2 | Identifies package type and size (Manufacturer-assigned) |
📌 Normalize to 11 digits by adding leading zeroes to any segment that does not meet its maximum length. Required for claims submission and electronic records.
NDC Format Example
- Printed NDC:
58160-823-52 - Normalized:
058160082352- Labeler:
058160 - Product:
0823 - Package:
52
- Labeler:
🛡️ Always verify the NDC on both the primary and secondary packaging during dispensing. Report discrepancies to a pharmacist immediately.
Barcoding and serialization are mandated under the Drug Supply Chain Security Act (DSCSA) to prevent counterfeit drugs and support recalls. Manufacturers must affix machine-readable codes to each smallest saleable unit.
| Barcode Type | Appearance | Contents | Use Case |
|---|---|---|---|
| Linear (1D) | Horizontal bars | NDC only | Used in shelf stock scanning or inventory |
| GS1 DataMatrix (2D) | Square pixel grid | GTIN + Expiration + Lot + Serial Number | Used in Rx filling & verification |
- 🔑 GTIN = Global Trade Item Number, a globally unique product identifier that incorporates the NDC and labeler code.
- 🛡️ Pharmacists and technicians must scan and verify 2D barcodes during prescription processing, especially for controlled substances and REMS drugs.
- 📌 Always inspect labels for tampering or misprints, especially if barcodes do not resolve in your system.
Dispensed prescription labels serve as the primary source of patient-facing instructions and must meet federal, state, and professional standards for clarity, safety, and accuracy. Technicians are responsible for ensuring that all required elements are present, legible, and consistent with the prescriber's order and the product dispensed. Errors in labeling can lead to medication misadventures, insurance rejections, and regulatory violations.
A complete prescription label must include the following components:
- Pharmacy Name
- Address
- Telephone Number
This information ensures patients and providers can contact the pharmacy for refills, clarifications, or clinical questions.
- Patient Name
- Patient Address (required in many states; always required for controlled substances)
Accurate patient identifiers prevent mix-ups and support insurance adjudication and controlled-substance tracking.
- Prescriber Name
- (Optional) Prescriber Address or DEA/NPI, depending on state requirements
- Prescription Number (Rx#)
- Appears as:
RxNumber–TransactionNumberwhen applicable
- Appears as:
- National Drug Code (NDC) or Drug Identification Number (DIN)
- Refill Information (e.g., “0 refills remaining”)
These fields support billing, refill management, and DSCSA traceability.
- Data Entry Technician Initials
- Filling Technician Initials
- Fill Date (“Date Dispensed”)
- Expiration Date
- Use stock bottle expiration or 1 year from fill date, whichever is sooner
- Space for Pharmacist Initials
- Signed during final verification
These elements document the workflow and support audit trails, quality assurance, and regulatory compliance.
- Inscription (drug name, strength, dosage form)
- Signa (patient instructions)
- Quantity Dispensed
The inscription and signa must match the prescriber's intent and be written in clear, patient-friendly language. Avoid abbreviations unless required by system formatting.
Depending on the medication, the system may prompt for:
- Shake well
- Take with food
- Avoid sunlight
- May cause drowsiness
- Refrigerate
- Controlled substance warnings
- Hazardous drug precautions
Technicians must verify that all required auxiliary labels are applied and that they do not obscure critical information.
🔐 Controlled Medication requires the label "Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed"
Dispensed medications must be placed in containers that:
- Preserve stability and integrity
- Are child-resistant unless exempted
- Are appropriately sized to avoid crushing or damaging tablets
- Include tamper-evident features when required
Refer to USP <659> Packaging & Storage and state board regulations for specifics.
- Always compare the NDC on the label, stock bottle, and system entry
- Ensure the drug name and strength match the product dispensed
- Confirm that the signa is complete, unambiguous, and readable
- Verify that the expiration date is correct and not copied incorrectly
- Ensure labels are applied straight, fully adhered, and not covering critical information
- For controlled substances, confirm all state‑specific warning labels are present
Accurate labeling is one of the most important safety steps in the dispensing workflow. Technicians must treat every label as a critical safety document, not just a sticker.
Risk Evaluation & Mitigation Strategies (REMS) are required safety programs for medications with known or potential serious risks that must be managed to ensure that the drug's benefits outweigh its risks; particularly those that are addictive (e.g. Opioids, Stimulants, Benzodiazepines), hazardous (e.g. Birth Control, Oncologics, Biologics), or understudied (e.g. Gabapentin).
Depending on the drug, a REMS program may include one or more of the following:
- Communication Plan
- Mandated Medication guides or patient package inserts (PPIs)
- Manufacturers are required to provide enough copies for distribution.
- Prescriber training and certification requirements
- Pharmacy certification and restricted dispensing systems
- Enrollment of patients in registries or special monitoring programs!
- e.g. iPLEDGE for Accutane due to severe birth defects
The FDA's Center for Drug Evaluation & Research (CDER) provides an Index to Drug-Specific information 🔗 Postmarket Drug Safety Information for Patients and Providers
labeling for potentially dangerous drug classes
PPIs are FDA-regulated documents that must accompany specific drug classes. They are not required for every outpatient medication. They are dispensed at:
- Retail Pharmacies with every fill/refill of a covered product.
- Institutions (e.g. hospital) before first administration, and every 30 days during therapy.
☣️ Common Drug Classes Requiring PPIs
| Class | Examples |
|---|---|
| Estrogens | Conjugated estrogens (Premarin), Estradiol |
| Oral Contraceptives | Combined hormonal products, Progestin-only pills |
| REMS-designated drugs | Isotretinoin, Mifepristone, etc |
🛡️ Failure to dispense a required PPI is a violation of FDCA §502(a), rendering the drug misbranded.
📂 Content Breakdown
| Section | What It Covers |
|---|---|
| Clinical Pharmacology | How the drug works in the body, including: Mechanism of action, Pharmacokinetics (absorption, distribution, metabolism, excretion), Demographic considerations (e.g., effects in children, pregnancy) |
| Approved Indications | Lists the FDA-approved uses of the drug (Drugs are sometimes used "off-label" for other conditions, that is not FDA-Approved, based on provider discretion.) |
| Contraindications | Situations where the drug should not be used, such as certain medical conditions, allergies, or interactions. |
| Boxed Warnings | Serious or life-threatening risks associated with the drug (inlcuding Black Box Warnings for serious risks). |
| Precautions | Instructions to help avoid harm, including guidance that informs auxiliary labels. |
| Side effects | Lists all known adverse reactions, including those reported during clinical trials or post-marketing. |
| Dosage & Administration Guide | How to take the medication, including dose, timing, route, and adjustments. |
| Overdose Protocol | Symptoms of overdose & instructions on how to handle. |
| Abuse Potential & Dependence | Details on the drug's potential for abuse, tolerance, or dependence (especially important for controlled substances). |
| How Supplied / Storage | Describes the drug's appearance (shape, color, imprint) and storage conditions (e.g., keep refrigerated, protect from light). |
📌 Many PPIs contain diagrams or step-by-step patient instructions, especially for complex dosage forms (e.g., vaginal rings, inhalers, patches).
PPIs arrive with the product, but can also be found online at the 🔗 Physicians' Desk Reference (PDR).
labeling for specific drugs
MedGuides are FDA-required patient labeling for outpatient prescription drugs that present serious and specific public health concerns. These are distinct from PPIs and are drug-specific, not class-based.
A MedGuide must be dispensed if any of the following conditions apply:
| Trigger | Description |
|---|---|
| Patient labeling could prevent serious adverse effects | The drug has significant risks that could be avoided or reduced by patient understanding |
| Serious risks that could affect decision to use | The drug has known dangers that might change a patient's willingness to begin or continue therapy |
| Adherence is crucial to effectiveness | Incorrect use of the medication would result in ineffective treatment or increased risk |
MedGuides must be dispensed in:
- Outpatient Settings with each fill & refill
- Inpatient Settings only if drug is part of a REMS program.
🚨 Failure to provide a required MedGuide renders the drug misbranded under federal law, even if all other labeling is correct.
📂 Content Breakdown
| Section | What It Explains |
|---|---|
| What is the most important information I should know? | Key risks and dangers |
| What is [Drug Name]? | Description and indication |
| Who should not take [Drug]? | Contraindications |
| How should I take [Drug]? | Dosing, missed doses |
| What should I avoid? | Drug/food/alcohol interactions |
| Possible side effects | Sorted by severity |
| How do I store [Drug]? | Storage and handling |
| General information | Encourages patients to ask their pharmacist or doctor for more details |
- 🛡️ Always verify MedGuide availability in your pharmacy system. Most eRx platforms and label software include print flags for drugs that require them.
MedGuides & Complete Labeling can be found on the 🔗 National Library of Medicine's (NLM) DailyMed Database.
- 🔙🔗 Back to Production, Marketing, & Distribution of Medicine
- 🔙🔗 Back to 🛠️ SOP — Filling Prescriptions